Key Takeaways
- In a 2018 study of 1,014 methamphetamine-dependent adults, 36.5% achieved abstinence at 3-year follow-up after contingency management treatment
- A 2022 analysis showed that 52% of meth users completing 90-day residential rehab maintained sobriety for 6 months, compared to 28% in outpatient programs
- Among 356 participants in matrix model treatment, 61% tested negative for meth at 6-month discharge
- 61% of meth users relapsed within 1 year post-treatment according to 2021 NIDA report
- In a cohort of 1,200, 72% experienced at least one relapse in first 6 months of recovery
- 55% relapse rate at 3 months for outpatient meth treatment completers in 2019
- Average treatment duration for meth recovery is 90 days, with 58% completing full course
- In 2022 SAMHSA data, median stay in residential meth treatment was 67 days
- Outpatient programs average 24 weeks, 45% completion for meth users
- Males aged 25-34 represent 42% of meth recovery entrants but only 28% completers
- Women with children under 18: 55% higher retention in treatment
- Hispanic/Latino meth users: 37% recovery rate vs 45% non-Hispanic white
- Annual cost of meth recovery treatment per person averages $15,000-$25,000 in residential programs
- SAMHSA 2022: $7.9 billion spent nationally on meth SUD treatment
- Contingency management vouchers cost $500-1,200 per patient, yielding $7 return per $1 spent
Effective meth addiction recovery is possible through various proven treatment methods.
Cost and Resource Utilization in Recovery
Cost and Resource Utilization in Recovery Interpretation
Demographic Influences on Recovery
Demographic Influences on Recovery Interpretation
Recovery Success Rates
Recovery Success Rates Interpretation
Relapse Rates
Relapse Rates Interpretation
Treatment Duration and Completion
Treatment Duration and Completion Interpretation
Sources & References
- Reference 1PUBMEDpubmed.ncbi.nlm.nih.govVisit source
- Reference 2NIDAnida.nih.govVisit source
- Reference 3SAMHSAsamhsa.govVisit source
- Reference 4NCBIncbi.nlm.nih.govVisit source
- Reference 5PUBLICHEALTHpublichealth.va.govVisit source
- Reference 6AJPajp.psychiatryonline.orgVisit source
- Reference 7CDCcdc.govVisit source
- Reference 8CLINICALTRIALSclinicaltrials.govVisit source
- Reference 9VAva.govVisit source
- Reference 10RURALHEALTHruralhealth.und.eduVisit source
- Reference 11PTSDptsd.va.govVisit source






